Artificial intelligence technology to detect diabetic retinopathy



[ad_1]

Dubai: In an effort to reduce the growing incidence of diabetes, the Dubai Diabetes Center (DDC) plans to introduce artificial intelligence to detect retinopathy, begin telemonitoring patients that are lacking their appointments and introduce obesity clinics in the emirate

Elaboration on the use of artificial intelligence Dr. M Hamed Farooqi, director of the multidisciplinary center, said: "According to international standards on diabetes, we must have 14 retinal images per diabetic.The estimated number of diabetics diagnosed in the UAE exceeds one million.To interpret 14 million images per year, we need more than 50 eye specialists working full-time.The deep learning system (DLS) using artificial intelligence is able to identify diabetic retinopathy and ocu diseases. badociated with using retinal images with a high degree of accuracy. Thus, the use of AI can not only help provide screening for retinopathy to a large number of diabetics but also lead to better use of resources and time of ophthalmologists.

Dr. Farooqi adds, "The use of artificial intelligence in diabetic retinopathy We examine patients, reduce time, make the process cost-effective, and provide high quality care that will lead to better outcomes." resource use.Ophthalmologists will only need to see retinal images of retinopathy patients that the system detects rather than "

Humaid Al Qutami, Executive Director of the Dubai Health Authority (DHA), paid a visit to The center and received a detailed overview of recent achievements and progress made. plans for the expansion of the center.

Al Qutami pointed out that DHA aims to provide specialized medical services. "Since the beginning of this center in 2009, we have come a long way in ensuring that we provide specialized services to people with diabetes under one roof, and we are eager to expand the services of this center for to improve the capacity and provide high quality multidisciplinary diabetes care to a greater number of patients. "

Dr. Ahmed Bin Kalban, CEO of the DHA Specialized Care Services Sector. in particular is a disease that requires specialized multidisciplinary care. At the center, we provide care internationally and trained North American specialists such as adult consultants and pediatric endocrinologists, as well as nurse educators, dieticians, podiatrists, physiotherapists and retinal technicians. . Continuity of care is an integral part of the Center and each patient visits the same consultant each time. Due to the continuous addition of patients, the number of existing patients has increased significantly causing a delay in obtaining new appointments to the patient. Expansion of existing facilities will allow us to treat more new patients and help us provide the usual level of care at the same time.

Obesity Clinic

The Center will soon open an obesity clinic to help patients struggling with obesity with realistic and effective ways to lose weight and maintain this weight loss too.

Dr. Farooqi said, "The management of patients whose significant obesity and its underlying complications is a huge challenge.Statistics clearly point out that obesity is one of the major factors contributing to the high prevalence of diabetes in the region.We already have experts in our center who will train a multidisciplinary team dedicated to helping obese patients to lose weight.The multidisciplinary team will include: [19659002] • Endocrinologists

• Dietitians

• Nursing Educators

• Exercise Physiologists

• Behavior Therapists (Psychologists)

Telemonitoring Technology for Diabetic Patients: [19659002] Dr Farooqi added that the Center is also working on another pilot study, which aims to study the effective use of telemonitoring in patients present for follow-up visits and, therefore, have poor diabetes control. These patients then place a significant burden on the health system as a result of the resulting complications.

The main objective of this study, according to Dr. Farooqi, is to study the use of telemonitoring devices (such as those for blood glucose, blood pressure, weight, pulse oximetry, pulse and ECG, spirometry and point-of-care laboratory, etc.) to collect relevant data in patients with type 2 diabetes and use mobile phone applications to promote adherence in these patients

. "The other goal is to evaluate the Center's electronic health records database using AI and DML to identify, if possible, trends or links that would lead to better predictive modeling of patients who are more likely to be lost. top Through the use of technology, we aim to empower patients and improve patient care, "he added.

[ad_2]
Source link